G1 Therapeutics (GTHX) OCF US GAAP (year values) |
|||||||||
| FY2019 | FY2020 | FY2021 | FY2022 | FY2023 | LTM ? | CAGR 5 years ? | |||
| OCF, bln rub | ? | -99.6 | -83.7 | -132.1 | -128.6 | -38.3 | -37.5 | ||
| Changes by years, y/y, % | +34% | -16% | +58% | -3% | -70% | -12.4% | |||
G1 Therapeutics. OCF, bln rub
G1 Therapeutics. OCF, changes, %
G1 Therapeutics. OCF, sum by quarters, bln rub
G1 Therapeutics (GTHX) OCF US GAAP (quarter values) |
||||||||
| FY2023Q2 | FY2023Q3 | FY2023Q4 | FY2024Q1 | FY2024Q2 | LTM ? | |||
| OCF, bln rub | ? | 14.1 | -10.6 | -12.8 | -8.90 | -5.27 | -37.5 | |
| Changes by years, y/y, % | -137% | -50% | -58% | -69% | -137% | |||
| Changes by quarters, q/q, % | -148% | -175% | +21% | -30% | -41% | |||